ISO 20387:2018 General Requirements for Biobank Operation in Biotech Testing
In the realm of pharmaceutical and biotechnology testing, maintaining high standards of quality control is crucial. One essential aspect of this process is ensuring that biological samples are stored and handled with precision to preserve their integrity. This is where ISO 20387:2018 comes into play a set of guidelines for the operation of biobanks in biotech testing.
Real-World Applications in Biotechnology
Biobanks are repositories for storing, managing, and distributing valuable biological samples such as cells, tissues, or DNA. In the context of biotechnology, these resources are vital for research and development, product manufacturing, and quality control. Companies like those working with gene therapies, vaccines, or cell-based products rely heavily on biobank services to access relevant biological materials.
Biobanks play a critical role in various industries:
- Pharmaceuticals: Biobanks support the discovery and development of new medicines by providing researchers with samples for testing.
- Biotechnology: Companies use biobanked materials for cell culture, gene expression analysis, and other downstream applications.
- Regenerative Medicine: Tissue banks store human tissues for use in regenerative therapies.
Clear Explanation of How the Testing is Performed
The ISO 20387 standard sets out guidelines for establishing and operating a biobank. This includes requirements for infrastructure, equipment, personnel training, quality management systems, document control, records management, sample collection, labeling, tracking, storage, distribution, testing, analysis, release, recall, deviation reporting, complaint handling, corrective action, preventive action, internal audits, management review, and continual improvement.
In essence, biobank operations are subject to strict regulatory oversight to ensure compliance with international standards. Biobanked materials undergo rigorous testing for:
- Identity: Verification of the biological materials identity.
- Purity: Confirmation that the sample is free from contaminants or extraneous substances.
- Potency: Assay of the biological activity of the stored material.
The testing process involves several steps, including but not limited to:
1. Sample collection and labeling
2. Storage and retrieval procedures
3. Testing protocols for identification, purity, and potency
4. Data analysis and reporting
Risks and Legal Implications of Skipping the Service
Non-compliance with ISO 20387:2018 exposes biobanks to severe risks, including:
- Loss of accreditation: Non-compliant biobanks may face loss of accreditations or licenses from regulatory bodies.
- Reputational damage: Deviations from standards can harm a companys reputation and credibility in the industry.
- Liability for sample contamination: Failure to adhere to storage protocols can lead to costly recalls, replacements, or even product liability claims.
Moreover, skipping these testing protocols increases the risk of:
Sample degradation or contamination
Inaccurate test results leading to poor decision-making
Regulatory non-compliance and associated penalties
Damage to company reputation and credibility
Key Commercial Advantages for Clients
Choosing a certified biobank that adheres to ISO 20387:2018 offers numerous benefits, including:
- Reliability: High-quality materials are guaranteed, minimizing the risk of test failure or product rejection.
- Efficiency: Streamlined processes ensure faster access to biological samples, reducing RD timelines.
- Cost Savings: Reduced risk of sample contamination and rework enables cost savings for companies.
- Compliance: Adherence to international standards ensures regulatory compliance and mitigates potential risks.
By opting for certified biobank services, clients can:
Enhance product quality and efficacy
Reduce development timelines and costs
Mitigate regulatory risk
Ensure consistency in their processes
FAQs
How do I know if my biobank is compliant with ISO 20387:2018?
- You can verify compliance by checking accreditations or certifications from recognized bodies.
What are the main differences between different biobanking standards (e.g., ISO 20387:2018, ASTM E2504)?
- Each standard has unique requirements. For example, ISO 20387 focuses on general requirements for biobank operation, while ASTM E2504 covers specific testing protocols for certain biological materials.
Can I store my own samples in-house instead of using a third-party biobank?
- While its technically possible to store your own samples, hiring a certified biobank ensures access to specialized expertise and equipment, mitigating potential risks.
By understanding the importance of ISO 20387:2018 in maintaining high standards for biological sample storage and handling, companies can ensure compliance and reap numerous commercial benefits.
